| The use of interferon gamma inducible protein 10 as a potential biomarker in the diagnosis of latent tuberculosis infection in Uganda IA Biraro, S Kimuda, M Egesa, S Cose, EL Webb, M Joloba, SG Smith, ... PloS one 11 (1), e0146098, 2016 | 58 | 2016 |
| Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders’ meeting held in … AM Elliott, M Roestenberg, A Wajja, C Opio, F Angumya, M Adriko, ... AAS open research 1, 2, 2018 | 44 | 2018 |
| Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort IA Biraro, M Egesa, F Toulza, J Levin, S Cose, M Joloba, S Smith, ... PLoS One 9 (11), e111517, 2014 | 41 | 2014 |
| Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study IA Biraro, M Egesa, S Kimuda, SG Smith, F Toulza, J Levin, M Joloba, ... BMC infectious diseases 15, 1-12, 2015 | 40 | 2015 |
| Schistosoma mansoni schistosomula antigens induce Th1/Pro‐inflammatory cytokine responses M Egesa, L Lubyayi, EM Tukahebwa, BS Bagaya, IW Chalmers, S Wilson, ... Parasite immunology 40 (12), e12592, 2018 | 34 | 2018 |
| Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses SW Stonier, AS Herbert, AI Kuehne, A Sobarzo, P Habibulin, CVA Dahan, ... Journal of Experimental Medicine 214 (9), 2563-2572, 2017 | 31 | 2017 |
| The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette–Guérin immunization PA Mawa, G Nkurunungi, M Egesa, EL Webb, SG Smith, R Kizindo, ... Philosophical Transactions of the Royal Society B: Biological Sciences 370 …, 2015 | 30 | 2015 |
| Rethinking schistosomiasis vaccine development: synthetic vesicles M Egesa, KF Hoffmann, CH Hokke, M Yazdanbakhsh, S Cose Trends in parasitology 33 (12), 918-921, 2017 | 27 | 2017 |
| Type 2 diabetes mellitus and latent tuberculosis infection moderately influence innate lymphoid cell immune responses in Uganda P Ssekamatte, M Nakibuule, R Nabatanzi, M Egesa, C Musubika, ... Frontiers in immunology 12, 716819, 2021 | 14 | 2021 |
| The genetics of human schistosomiasis infection intensity and liver disease: A review EM Mewamba, OA Nyangiri, HA Noyes, M Egesa, E Matovu, G Simo Frontiers in Immunology 12, 613468, 2021 | 13 | 2021 |
| Antibody responses to Schistosoma mansoni schistosomula antigens M Egesa, L Lubyayi, FM Jones, A van Diepen, IW Chalmers, ... Parasite immunology 40 (12), e12591, 2018 | 13 | 2018 |
| Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses SG Kimuda, I Andia-Biraro, M Egesa, BS Bagaya, JG Raynes, J Levin, ... PLoS One 12 (11), e0188396, 2017 | 12 | 2017 |
| UCP-LF and other assay methods for schistosome circulating anodic antigen between 1978 and 2022 IV Fasogbon, PM Aja, EN Ondari, I Adebayo, OA Ibitoye, M Egesa, ... Biology Methods and Protocols 8 (1), bpad006, 2023 | 10 | 2023 |
| Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda M Egesa, A Ssali, E Tumwesige, M Kizza, E Driciru, F Luboga, ... Global Bioethics 33 (1), 78-102, 2022 | 10 | 2022 |
| Correspondence of neutralizing humoral immunity and CD4 T cell responses in long recovered Sudan virus survivors A Sobarzo, SW Stonier, AS Herbert, DE Ochayon, AI Kuehne, Y Eskira, ... Viruses 8 (5), 133, 2016 | 10 | 2016 |
| Mosquito-borne arboviruses in Uganda: history, transmission and burden MN Mayanja, FN Mwiine, JJ Lutwama, A Ssekagiri, M Egesa, ... Journal of General Virology 102 (6), 001615, 2021 | 8 | 2021 |
| Mycobacterium tuberculosis infection is associated with increased B cell responses to unrelated pathogens SG Kimuda, I Andia-Biraro, I Sebina, M Egesa, A Nalwoga, SG Smith, ... Scientific reports 10 (1), 14324, 2020 | 8 | 2020 |
| Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda JP Koopman, M Egesa, A Wajja, M Adriko, J Nassuuna, G Nkurunungi, ... AAS open research 2, 17, 2019 | 6 | 2019 |
| Fourth controlled human infection model (CHIM) meeting, CHIM regulatory issues, May 24, 2023 M Cavaleri, D Kaslow, E Boateng, WH Chen, C Chiu, RKM Choy, ... Biologicals 85, 101745, 2024 | 5 | 2024 |
| Transcriptome analysis of peripheral blood of Schistosoma mansoni infected children from the Albert Nile region in Uganda reveals genes implicated in fibrosis … J Namulondo, OA Nyangiri, MP Kimuda, P Nambala, J Nassuuna, ... PLoS neglected tropical diseases 17 (11), e0011455, 2023 | 5 | 2023 |
